Neuromodulation of pharyngeal nerves to treat diseases
US-2024366279-A1 · Nov 7, 2024 · US
US10117710B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10117710-B2 |
| Application number | US-201514876515-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 6, 2015 |
| Priority date | Oct 7, 2014 |
| Publication date | Nov 6, 2018 |
| Grant date | Nov 6, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An endometrial tissue treatment device includes an elongate positioning member and an energy applicator coupled to a distal end of the positioning member, the energy applicator including a tissue contacting member and an expandable-collapsible support structure underlying the tissue contacting member, the expandable-collapsible support structure comprising a substantially non-compliant elongate balloon disposed within the tissue contacting member that, when inflated, has a length oriented substantially transverse to the positioning member, including a first closed end that positions a corresponding first corner portion of the tissue contacting member in a first cornu of a uterine cavity, and a second closed end that positions a corresponding second corner portion of the tissue contacting member in a second cornu of a uterine cavity, with a lengthwise portion of the balloon positioning a distal facing portion of the tissue contacting member for contacting a fundal wall of a uterus.
Opening claim text (preview).
What is claimed is: 1. An endometrial tissue treatment device, comprising: an elongate positioning member; and an energy applicator coupled to a distal end of the positioning member, the energy applicator comprising a tissue contacting member and an expandable-collapsible support structure underlying the tissue contacting member, the expandable-collapsible support structure comprising a substantially non-compliant elongate balloon disposed within a distal portion of the tissue contacting member that, when inflated within a uterus, has a lengthwise dimension oriented substantially transverse to the positioning member that spans a fundal wall of the uterus extending between a first corner portion of the tissue contacting member positioned in a first cornu of the uterus and a second corner portion of the tissue contacting member positioned in a second cornu of the uterus, such that the tissue contacting member is disposed between a distal facing surface of the inflated balloon and the fundal wall of the uterus, the inflated balloon having a widthwise dimension transverse to the lengthwise dimension, wherein the widthwise dimension of the inflated balloon is less than half the lengthwise dimension. 2. The endometrial tissue treatment device of claim 1 , further comprising an elongate hollow delivery sheath having a distal portion configured for transcervical placement into the uterus, the delivery sheath having a lumen and an open distal end in communication with the delivery sheath lumen, wherein the respective positioning member and energy applicator are slidably disposed in the delivery sheath lumen so that the energy applicator slidably moves between a collapsed configuration in which the energy applicator is at least partially withdrawn through the open distal end of the delivery sheath and into the delivery sheath lumen, and an extended configuration in which the energy applicator is extended out the open distal end of the delivery sheath and at least partially self-expanded to conform to the uterus. 3. The endometrial tissue treatment device of claim 2 , wherein the delivery sheath and positioning member are operatively coupled to an actuator that moves the positioning member relative to the delivery sheath to thereby move the energy applicator between the collapsed configuration and the extended configuration. 4. The endometrial tissue treatment device of claim 1 , further comprising at least one inflation member having an inflation lumen fluidly coupled to an interior of the balloon, with a proximal end of the respective inflation member configured for fluidly coupling the respective inflation lumen with a source of inflation media. 5. The endometrial tissue treatment device of claim 1 , further comprising an elongate tensioning member that is movable relative to the positioning member, the tensioning member having a distal end fixed to the balloon at an approximate lengthwise midpoint of the balloon. 6. The endometrial tissue treatment device of claim 5 , wherein the distal end of the tensioning member comprises, or is otherwise connected to, a ring member that at least partially circumferentially surrounds the balloon at the approximate lengthwise midpoint of the balloon. 7. The endometrial tissue treatment device of claim 1 , the support structure further comprising opposing first and second flexures disposed within the tissue contacting member, the flexures having a delivery configuration in which the flexures are in a side-by-side configuration aligned with the positioning member, and a deployed configuration in which a distal end of the first flexure is positioned in the first corner portion of the tissue contacting member, and a distal end of the second flexure is positioned in the second corner portion of the tissue contacting member, the first and second flexures having arcuate outer surfaces. 8. The endometrial tissue treatment device of claim 7 , wherein in the side-by-side delivery configuration, the arcuate outer surfaces of the first and second flexures together define a cylindrical outer surface. 9. The endometrial tissue treatment device of claim 7 , wherein in the side-by-side delivery configuration, the distal ends of the first and second flexures together define a tapered or rounded tip. 10. The endometrial tissue treatment device of claim 7 , the first and second flexures each comprising one or more embedded conductors, each conductor electrically connected to a respective portion of the tissue contacting member. 11. The endometrial tissue treatment device of claim 7 , wherein at least one of the first and second flexures comprises an embedded inflation lumen fluidly coupled to an interior of the balloon. 12. The endometrial tissue treatment device of claim 1 , wherein the tissue contacting member is moisture permeable. 13. The endometrial tissue treatment device of claim 1 , further comprising an actuator including a grip-style handle that is actuated by squeezing together a pair of pivotably connected grip members. 14. The endometrial tissue treatment device of claim 1 , further comprising an aspiration lumen extending through the positioning member and having an open distal end located within the support structure.
having a short rigid shaft for accessing the inner body through natural openings · CPC title
Female reproductive organs · CPC title
characterised by balloon shape (A61M25/1006, A61M25/1009 take precedence) · CPC title
Electrodes retractable in or deployable from a housing · CPC title
Balloons · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.